Savant Capital LLC Increases Holdings in Tenet Healthcare Co. (NYSE:THC)

Savant Capital LLC grew its stake in shares of Tenet Healthcare Co. (NYSE:THC) by 10.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,439 shares of the company’s stock after acquiring an additional 699 shares during the quarter. Savant Capital LLC’s holdings in Tenet Healthcare were worth $939,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of THC. Empirical Finance LLC lifted its stake in shares of Tenet Healthcare by 69.0% in the fourth quarter. Empirical Finance LLC now owns 8,360 shares of the company’s stock worth $1,055,000 after buying an additional 3,414 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Tenet Healthcare by 55.6% in the 4th quarter. Empowered Funds LLC now owns 129,431 shares of the company’s stock worth $16,338,000 after purchasing an additional 46,270 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Tenet Healthcare by 1,352.8% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock valued at $66,000 after purchasing an additional 487 shares in the last quarter. Lecap Asset Management Ltd. raised its position in Tenet Healthcare by 152.7% in the 4th quarter. Lecap Asset Management Ltd. now owns 4,189 shares of the company’s stock worth $529,000 after buying an additional 2,531 shares during the last quarter. Finally, Hedeker Wealth LLC bought a new stake in shares of Tenet Healthcare in the fourth quarter worth approximately $2,461,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of NYSE THC opened at $133.40 on Friday. The company has a market cap of $12.69 billion, a P/E ratio of 4.27, a P/E/G ratio of 0.63 and a beta of 2.05. The firm’s fifty day moving average is $133.32 and its two-hundred day moving average is $148.13. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. Tenet Healthcare Co. has a 52-week low of $88.57 and a 52-week high of $171.20.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. As a group, analysts anticipate that Tenet Healthcare Co. will post 11.37 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. StockNews.com downgraded shares of Tenet Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday. Truist Financial dropped their target price on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada upped their price target on shares of Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Wells Fargo & Company lowered shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $205.00 to $150.00 in a research report on Monday, November 25th. Finally, UBS Group lifted their price target on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research note on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $163.19.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.